Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Indocyanine Green × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Endometrial Neoplasms 4 Lymphedema 3 Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Suspected Central Nervous System Tumors 1 Stomach Neoplasms 1 Skull Base Neoplasms 1 Pediatric Patients With Solid Tumors 1 Mixed Tumor, Mesodermal 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Diseases 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholecystitis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡